Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by wyndeweston Sep 08, 2021 7:26pm
174 Views
Post# 33829090

RE:RE:T/A...Levels...

RE:RE:T/A...Levels...And Stockbufoon I do wonder why?  4050 has always had the potential to be a blockbuster drug. Certainly Liminal has chosen to minimize it's value. Why? I'm pretty sure I know the answer.  For sure time will tell. To me it looks like Liminal wants to take Prometic's' jewel in the crown' for themselves by scuttling this company. 4050 has so much potential value it's off the chart but no common investor will be part of the succes story.
<< Previous
Bullboard Posts
Next >>